Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex vs Neostigmine for Prevention of Postoperative Pulmonary Complications
NCT02825576Phase 4Terminated
- Sponsor
- Northern Sydney Anaesthesia Research Institute
- Start
- Dec 2018
- Primary completion
- Apr 2020
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Sugammadex in postoperative pulmonary complications (PPC), sponsored by Northern Sydney Anaesthesia Research Institute. Started Dec 2018; status: terminated.
02
Drugs
Sugammadex
03
Conditions
postoperative pulmonary complications (PPC)
Beyond the preview
Go deeper on NCT02825576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02825576.